Purified promyelocytic leukemia coiled-coil aggregates as a tetramer displaying low α-helical content

Protein Expression and Purification

Volumn 29, Issue 1, 2003, Pages 94-102

  Antolini, Francesco ^a,c   Lo Bello, Mario ^b   Sette, Marco ^b  

^a Appl Biochem/Clin Chem Section   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Centro Ricerche Brindisi   (Italy)

Author keywords

Circular dichroism; FPLC purification; HPLC; PML

Indexed keywords

EID: 0037518223     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(03)00004-4     Document Type: Article

References (49)

1. D. Ruggero, Z.G. Wang, P.P. Pandolfi, The puzzling multiple lives of PML and its role in the genesis of cancer, Bioassays 22 (2000) 827-835.
2. F. Grignani, M. Fagioli, M. Alcalay, L. Longo, P.P. Pandolfi, E. Donti, E. Biondi, F. Lo Coco, F.M Grinani, P.G. Pelicci, Acute promyelocytic leukemia: from genetics to treatment, Blood 1 (1994) 10-25.
3. X. Le, P. Yang, K. Chang, Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML, J. Biol. Chem. 271 (1996) 130-135.
4. Z. Mu, K. Chin, J. Liu, G. Lozano, K. Chang, A growth suppressor disrupted in acute promyelocytic leukemia, Mol. Cell. Biol. 14 (1994) 6858-6867.
5. M. Fagioli, M. Alcalay, L. Tomassoni, P.F. Ferrucci, A. Mencarelli, D. Riganelli, F. Grignani, T. Pozzan, I. Nicoletti, F. Grignani, P.G. Pelicci, Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival, Oncogene 16 (1998) 2905-2913.
6. Z.G. Wang, L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, P.P. Pandolfi, Role of PML in cell growth and the retinoic acid pathway, Science 279 (1998) 1547-1551.
7. F. Quignon, F. De Bels, M. Koken, J. Feunteun, J.C. Ameisen, H. de The, PML induces a novel caspase-independent death process, Nat. Genet. 20 (1998) 259-265.
8. A. Guo, P. Salomoni, J. Luo, A. Shih, S. Zhong, W. Gu, P. Paolo Pandolfi, The function of PML in p53-dependent apoptosis, Nat. Cell Biol. 2 (2000) 730-736.
9. H. Li, J.D. Chen, PML and the oncogenic nuclear domains in regulating transcriptional repression, Curr. Opin. Cell Biol. 12 (2000) 641-644.
10. V. Doucas, The promyelocytic (PML) nuclear compartment and transcription control, Biochem. Pharmacol. 60 (2000) 1197-1201.
11. M. Pearson, R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P.P. Pandolfi, P.G. Pelicci, PML regulates p53 acetylation and premature senescence induced by oncogenic Ras, Nature 406 (2000) 207-210.
12. J.A. Dyck, G.G. Maul, W.H. Miller, J. Don Chen, A. Kakizuka, R.M. Evans, A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein, Cell 76 (1994) 333-343.
13. M.H.M. Koken, Puvio-Dutilleul, M.C. Guillemin, A. Viron, G. Cruz-Linares, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, H. de Thè, The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion, EMBO J. 14 (1994) 1073-1083.
14. C. Kretz-Remy, R.M. Tanguay, SUMO/sentrin: protein modifiers regulating important cellular functions, Biochem. Cell Biol. 77 (1999) 299-309.
15. A.I. Lamond, W.C. Earnshaw, Structure and function in the nucleus, Science 280 (1998) 547-553.
16. J.A. Costoya, P.P. Pandolfi, The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development, Curr. Opin. Hematol. 8 (2001) 212-217.
17. S. Zhong, S. Muller, S. Ronchetti, P.S. Freemont, A. Dejean, P.P. Pandolfi, Role of SUMO-1-modified PML in nuclear body formation, Blood 95 (2000) 2748-2753.
18. C.A. Ascoli, G.G. Maul, Identification of a novel nuclear domain, J. Cell. Biol. 112 (1991) 785-795.
19. S. Torii, D.A. Egan, R.A. Evans, J.C. Reed, Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs), EMBO J. 18 (1999) 6037-6049.
20. V. Fogal, M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P.P. Pandolfi, H. Will, C. Schneider, G. Del Sal, Regulation of p53 activity in nuclear bodies by a specific PML isoform, EMBO 19 (2000) 6185-6195.
21. M. Alcalay, L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, P.G. Pelicci, The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein, Mol. Cell. Biol. 18 (1998) 1084-1093.
22. V. Doucas, M. Tini, D.A. Egan, R.M. Evans, Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling, Proc. Natl. Acad. Sci. USA 96 (1999) 2627-2632.
23. S. Zhong, P. Hu, T.Z. Ye, R. Stan, N.A. Ellis, P.P. Pandolfi, A role for PML and the nuclear body in genomic stability, Oncogene 18 (1999) 7941-7947.
24. F. Grignani, V. Gelmetti, M. Fanelli, D. Rogaia, S. De Matteis, F.F. Ferrara, D. Bonci, F. Grignani, C. Nervi, P.G. Pelicci, Formation of PML/RAR α high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR α-mediated retinoic acid response, Oncogene 18 (1999) 6313-6321.
25. M.N. Boddy, K. Howe, L.D. Etkin, E. Solomon, P.S. Freemont, PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia, Oncogene 13 (1996) 971-982.
26. M. Fagioli, M. Alcalay, P.P. Pandolfi, L. Venturini, A. Mencarelli, A. Simeone, D. Acampora, F. Grignani, P.G. Pelicci, Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms, Oncogene 7 (1992) 1083-1091.
27. K.L. Borden, M.N. Boddy, J.M. Lally, N.J. O'Reilly, S.R. Martin, H. Katty, E. Solomon, P.S. Freemont, The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML, EMBO J. 14 (1995) 1532-1541.
28. K.L. Borden, J.M. Lally, S.R. Martin, N.J. O'Reilly, E. Solomon, P.S. Freemont, In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML, Prot. Natl. Acad. Sci. USA 93 (1996) 1601-1606.
29. P. Kastner, A. Perez, Y. Lutz, C. Rochette-Egly, M.P. Gaub, B. Durand, M. Lanotte, R. Berger, P. Chambon, Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins, EMBO J. 11 (1992) 629-642.
30. A. Kakizuka, R.H. Miller, K. Umesono, R.P. Warrel, S.R. Frankel, V.V.V.S. Murty, E. Dmitrovsky, R.M. Evans, Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR α with a novel putative transcription factor, PML, Cell 66 (1991) 663-674.
31. F. Grignani, U. Testa, D. Rogaia, P.F. Ferrucci, P. Samoggia, A. Pinto, D. Aldinucci, V. Gelmetti, M. Fagioli, M. Alcalay, J. Seeler, F. Grignani, I. Nicoletti, C. Peshle, P.G. Pelicci, Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein dimerization and RARα DNA binding domains, EMBO J. 15 (1996) 4949-4958.
32. A. Perez, P. Kastner, S. Sehti, Y. Lutz, C. Reibel, P. Chambon, PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR, EMBO J. 12 (1993) 3171-3182.
33. S. Minucci, M. Maccarana, M. Ciocie, P. De Luca, V. Gelmetti, S. Segalla, L. Di Croce, S. Giavara, C. Matteucci, A. Gobbi, A. Bianchini, E. Colombo, I. Schiavoni, G. Badaracco, X. Hu, M.A. Lazar, N. Landsberger, C. Nervi, P.G. Pelicci, Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation, Mol. Cell 5 (2000) 811-820.
34. R.J. Lin, R.M. Evans, Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers, Mol. Cell 5 (2000) 821-830.
35. F. Grignani, S. De Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F.F. Ferrara, I. Zamir, C. Seiser, F. Grignani, M.A. Lazar, S. Minucci, P.G. Pelicci, Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia, Nature 391 (1998) 815-818.
36. A. Lupas, Coiled-coils: new structures and new functions, TIBS 21 (1996) 375-382.
37. T.D. Mulhern, G.J. Howlett, G.E. Reid, R.J. Simpson, D.J. McColl, R.F. Anders, R.S. Norton, Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum, Biochemistry 34 (1995) 3479-3491.
38. M.J. Walker, The Protein Protocols Handbook, Humana press, Totowa, New Jersey, 1996.
39. P.M. Okamoto, B. Tripet, J. Litowski, R.S. Hodges, R.B. Vallee, Multiple distinct coiled-coils are involved in dynamin self-assembly, J. Biol. Chem. 274 (1999) 10277-10286.
40. E. Wolf, P.S. Kim, B. Berger, MultiCoil: a program for predicting two- and three-stranded coiled-coils, Protein Sci. 6 (1997) 1179-1189.
41. N.E. Zhou, C.M. Kay, R.S. Hodges, Synthetic model proteins. Positional effects of interchain hydrophobic interactions on stability of two-stranded α-helical coiled-coils, J. Biol. Chem. 267 (1992) 2664-2670.
42. R.T. Gampe Jr., V.G. Montana, M.H. Lambert, G.B. Wisely, M.V. Milburn, H.E. Xu, Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix, Genes Dev. 14 (2000) 2229-2241.
43. J.S. Vinkemeier, E. Soldaini, J.E. Darnell Jr., W.J. Leonard, The significance of tetramerization in promoter recruitment by Stat5, Mol. Cell. Biol. 19 (1999) 1910-1918.
44. T. Cao, K.L.B. Borden, P.S. Freemont, L.D. Etkin, Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution, J. Cell Sci. 110 (1997) 1563-1571.
45. J.H. Ahn, E.J. Brignole III, G.S. Hayward, Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML, Mol. Cell Biol. 18 (1998) 4899-4913.
46. K. Kamitani, K. Kito, H.P. Nguyen, H. Wada, T. Fukuda-Kamitani, E.T. Yeh, Identification of three major sentrinization sites in PML, J. Biol. Chem. 273 (1998) 675-682.
47. E. Duprez, A.J. Saurin, J.M. Desterro, V. Lallemand-Breitenbach, K. Howe, M.N. Boddy, E. Solomon, H. De The, R.T. Hay, P.S. Freemont, SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation, J. Cell. Sci. 112 (1999) 381-393.
48. A. Hanagan, J.D. Meyer, L. Johnson, M.C. Manning, C.E. Catalano, The phage lambda terminase enzyme: 2. Refolding of the gpNul subunit from the detergent-denatured and guanidinium hydrochloride-denatured state yields different oligomerization states and altered protein stabilities, Int. J. Biol. Macromol. 23 (1998) 37-48.
49. R.R. Burgess, Purification of overproduced Escherichia coli RNA polymerase o factors by solubilizing inclusion bodies and refolding from Sarkosyl, Methods Enzymol. 273 (1996) 145-149.